Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosis.

Therapeutic advances in neurological disorders(2023)

引用 0|浏览14
暂无评分
摘要
Routine use of such an assay would enable a better understanding of the safety of therapeutic antibody administration during pregnancy and lactation.
更多
查看译文
关键词
Natalizumab,breastfeeding,cerebrospinal fluid,milk,multiple sclerosis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要